Summary
- Main use
- Nutritional improvement through amino acid supplementation (e.g., in malnutrition and before or after surgery)
- Who receives it
- Adults · Children
- Adult administration
- ○ Peripheral intravenous administration: -Adults: Slowly administer 200~400 mL per dose by intravenous infusion. -Infusion rate: A rate of 200 mL over 120 minutes (approximately 25 drops per minute) is used as a guide; an amino acid amount of around 10 g per hour is desirable for utilization in the body, ○ Central venous administration: Continuously infuse 400~800 mL daily into a central vein according to the hyperalimentation fluid regimen. For efficient utilization of amino acids in the body, concomitant administration with a carbohydrate solution is desirable. In older patients and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.
- Child administration
- Infuse slowly in children. In children, adjust the dose and infusion rate as appropriate.
Ingredients
- L-Isoleucine0.56g / 100mL
- L-Leucine1.25g / 100mL
- L-Lysine Acetate1.24g / 100mL
- L-Methionine0.35g / 100mL
- L-Phenylalanine0.935g / 100mL
- L-Threonine0.65g / 100mL
- L-Tryptophan0.13g / 100mL
- L-Valine0.45g / 100mL
- L-Alanine0.62g / 100mL
- L-Arginine0.79g / 100mL
- L-Aspartic Acid0.38g / 100mL
- L-Cysteine0.1g / 100mL
- L-Glutamic Acid0.65g / 100mL
- L-Histidine0.6g / 100mL
- L-Proline0.33g / 100mL
- L-Serine0.22g / 100mL
- L-Tyrosine35mg / 100mL
- Glycine1.07g / 100mL
- Manufacturer
- Hanool BioPharma Co., Ltd.
Efficacy & effects
Nutritional improvement through amino acid supplementation (e.g., in malnutrition and before or after surgery)
- Hypoproteinemia
- malnutrition
View approved original textHide original text
Amino acid supply is used in cases of hypoproteinemia or malnutrition, and before and after surgery.
How it is given
Adult administration
○ Peripheral intravenous administration: -Adults: Slowly administer 200~400 mL per dose by intravenous infusion. -Infusion rate: A rate of 200 mL over 120 minutes (approximately 25 drops per minute) is used as a guide; an amino acid amount of around 10 g per hour is desirable for utilization in the body, ○ Central venous administration: Continuously infuse 400~800 mL daily into a central vein according to the hyperalimentation fluid regimen. For efficient utilization of amino acids in the body, concomitant administration with a carbohydrate solution is desirable. In older patients and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.
Child administration
Infuse slowly in children. In children, adjust the dose and infusion rate as appropriate.
Precautions
This medicine must be used strictly under the guidance of a physician, and should not be taken or discontinued on one's own. It should not be administered to patients with hepatic coma symptoms or those at risk of hepatic coma. Additionally, patients with severely impaired kidney function or elevated nitrogen levels in the blood should also avoid using this medication. Patients with issues in nitrogen metabolism, severe heart failure, pulmonary edema, very low or absent urine output, and those with high sodium or chloride levels or alkalosis in the blood should also not be administered this medicine. Patients with a history of myocardial infarction or those currently experiencing myocardial infarction should also avoid this medication. This medicine should be used cautiously in certain situations. For example, patients with severe acidosis, congestive heart failure, abnormal sodium or potassium levels, or impaired liver or kidney function should be carefully monitored when using this medicine. Moreover, one of the ingredients, sodium pyruvate, can cause allergic reactions and may trigger asthma attacks, especially in asthma patients, so caution is warranted. This medication may rarely cause hypersensitivity reactions manifesting as skin rashes, and occasionally gastrointestinal symptoms such as nausea or vomiting may occur. Cardiac symptoms may include discomfort in the chest, palpitations, tachycardia, and elevated blood pressure. Rapidly administering a high volume of this medicine can lead to metabolic acidosis due to blood acidification. Additionally, symptoms such as chills, fever, headache, respiratory distress, shock, bronchospasm, and urinary tract spasms may occur, so any abnormal symptoms should be reported to medical professionals immediately. This medication can cause metabolic complications, including metabolic acidosis, decreased phosphate in the blood, alkalosis, elevated blood sugar, diabetes, dehydration, rebound hypoglycemia, liver dysfunction, vitamin imbalances, and electrolyte imbalances. Patients with poor liver or kidney function may experience elevated blood urea nitrogen levels, and patients with liver dysfunction may be at risk of amino acid imbalance and altered consciousness. When this medication is used in large volumes or in conjunction with other electrolyte-containing fluids, care must be taken to monitor electrolyte balance, as overdose could lead to blood becoming alkaline. Patients with a history of kidney, pulmonary, or cardiac diseases require careful administration to avoid fluid overload issues. Diabetic patients should regularly monitor blood sugar levels while using this medication. Caution is advised when this medication is used alongside certain antibiotics, such as tetracycline, as it may reduce protein-sparing effects. The safety of this medication during pregnancy has not been fully established, so it should only be used during pregnancy when the benefits outweigh the risks. For pediatric patients, maintaining lower concentrations is advisable due to potentially immature liver function, and particularly in infants, ammonia levels should be regularly monitored. Elderly patients may have diminished physical function; therefore, the administration speed should be slowed and dosing adjusted appropriately. This medicine contains electrolytes, and rapid administration may lead to side effects such as chills or vomiting, thus it should be slowly infused intravenously. The infusion fluids should be warmed to body temperature and strict aseptic conditions should be maintained during preparation and administration, confirming that the solution is clear and transparent before use. Do not use if there are residuals or discolorations, or leaks, and use as soon as possible after mixing, within 24 hours if refrigerated. During storage, do not open the packaging and do not use if the protective film over the rubber cap is damaged. Exact dosing should be administered according to the markings on the container.
Side effects
- Rash
- nausea
- vomiting
- chest discomfort
- palpitations
- tachycardia
- hypertension
- acidosis
- chills
- fever
Show 26 moreCollapse
- headache
- dyspnea
- respiratory failure
- shock
- bronchospasm
- ureteral spasm
- metabolic acidosis
- hypophosphatemia
- alkalosis
- hyperglycemia
- diabetes mellitus
- osmotic diuresis
- dehydration
- rebound hypoglycemia
- elevated liver enzymes
- vitamin deficiency
- vitamin excess
- electrolyte imbalance
- pediatric hyperammonemia
- elevated BUN
- serum amino acid imbalance
- metabolic alkalosis
- systemic nitrogenemia
- hyperammonemia
- sensory loss
- coma
Not everyone experiences these, and they can vary from person to person.
Storage
This medicine should be stored in a sealed container to avoid exposure to air, and it is safest to store it at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the efficacy of the medication and prevent deterioration.
Appearance and packaging
Appearance
Colorless, transparent liquid contained in a colorless, transparent vial injection.
Package unit
200 mL/bottle, 250 mL/bottle, 500 mL/bottle
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.